⬇️ 下载 PDF
红蓝生物

🧬 抗人CRACC/SLAMF7参考抗体)

Anti-Human CRACC/SLAMF7 Reference Antibody

货号: RB9T37015063
💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
🏷️ 产品编码
RB9T37015063
🧬 中文名称
抗人CRACC/SLAMF7参考抗体)
📝 英文名称
Anti-Human CRACC/SLAMF7 Reference Antibody
📦 形态
Liquid
🧪 纯度
>95% purity as determined by SDS-PAGE.
🔹 内毒素水平
Please contact the lab for this information.
🔬 应用
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
🧫 表达系统
Mammalian Cells
🔢 登录号
Q9NQ25
🔹 宿主种属
Humanized
🔹 克隆性
Monoclonal
🔹 抗体亚型
IgG1-kappa
🔹 纯化方式
Protein A/G purified from cell culture supernatant.
🔹 浓度
1mg/ml
🔹 种属反应性
Human
🔹 靶标
SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
🔹 背景信息
Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents.
• SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin., PMID:28424516
• 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer., PMID:30347240
• CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma., PMID:23731618
• CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes., PMID:17878365
• The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders., PMID:40073958
• Hematologic Malignancies: Plasma Cell Disorders., PMID:28561703
• Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma., PMID:28356715
• 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes., PMID:11513145
• Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma., PMID:39060023
• Update on elotuzumab, a novel anti-SLAMF7 monoclonal antibody for the treatment of multiple myeloma., PMID:27533882
🏷️ 别名
ABBV-383, PR-1471272, ABBV-838, 1826819-57-1
🧴 储存缓冲液
0.01M PBS, pH 7.4.
❄️ 稳定性和储存
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
⚠️ For research use only. Not suitable for clinical or therapeutic use.